Detall de la convocatòria
Característiques
| Característica |
|---|
|
Objectiu de la convocatòria
This grant supports independent medical education initiatives aimed at improving the knowledge and understanding of patients with advanced ALK+ non-small cell lung cancer (NSCLC) and their care partners. |
|
Característiques principals
- Oncology-Lung cancer: advanced or metastatic ALK+ non-small cell lung cancer (NSCLC) - Preparation of patients and care partners for ALK inhibitor therapy, side-effect management, including what to expect during treatment and how to engage with their healthcare team. - Development of material pertaining to prompt side-effect (adverse events) recognition, including lifestyle recommendations, to preserve / support quality of life. - Development of tools that emphasize patient preferences, facilitate preference-informed decision-making, and ensure inclusivity and accessibility for example: providing multilingual resources. |
|
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact: Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00. Carol Barnwell: [email protected] Ext.: 1670 Marta López: [email protected] Ext.: 1576 |
|
Convocatòria (URL)
https://cdn.pfizer.com/pfizercom/2025-12/2026-ONC-ALKPatientEducation-IME.pdf?VersionId=xpM_HYh9.XPlgFuJ0hk0GJCCXiSVf9jp Submission through: https://www.cybergrants.com/pfizer/knowledge |
|
Requisits
|
|
Dotació
Up to $100,000 |
|
Durada
18 months |
Arxius
| Arxiu |
|---|
| 2026-ONC-ALKPatientEducation-IME.pdf |